Orforglipron, made by the same company that produces the GLP-1 medications Zepbound and Mounjaro (tirzepatide), is an oral medication undergoing FDA clinical tests for use in weight loss
Weeks 9 through 12 (second escalation): Another dose increase, still once daily
In systemic circulation, only about 12% of liraglutide exists in the unbound (free) form, while the remainder is reversibly bound to albumin, effectively serving as a depot that enables sustained pharmacological action
Miss that window, and the drug simply isn't absorbed properly
While the book does have fewer recipes than others on our list, people who are just starting out on a GLP-1 journey may find it less overwhelming to have fewer options, which gives them the opportunity to lean into more guidance
One is that when glucose levels are high, they trigger the pancreas to release insulin and suppress glucagon, which helps lower your blood sugar levels